Oncolytics opens enrollment of cancer drug trial

Oncolytics opens enrollment of cancer drug trial
Canadian drug developer Oncolytics Biotech Inc. said Tuesday it has opened enrollment for a late-stage trial of the cancer treatment candidate Reolysin.

Read more on AP via Yahoo! Finance

More Meth Drug Addiction Info: